AU3142793A - Transdermal delivery of (E)-1,2,5,6-tetrahydro-1-methyl-3-pyridine-carboxaldehyde-O- methyloxine HCL and related compounds in the treatment of cognitive disorders and for analgesia - Google Patents

Transdermal delivery of (E)-1,2,5,6-tetrahydro-1-methyl-3-pyridine-carboxaldehyde-O- methyloxine HCL and related compounds in the treatment of cognitive disorders and for analgesia

Info

Publication number
AU3142793A
AU3142793A AU31427/93A AU3142793A AU3142793A AU 3142793 A AU3142793 A AU 3142793A AU 31427/93 A AU31427/93 A AU 31427/93A AU 3142793 A AU3142793 A AU 3142793A AU 3142793 A AU3142793 A AU 3142793A
Authority
AU
Australia
Prior art keywords
methyloxine
carboxaldehyde
analgesia
tetrahydro
hcl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31427/93A
Inventor
Majid Mahjour
Galen Radebaugh
Zhara Rashidbaigi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of AU3142793A publication Critical patent/AU3142793A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU31427/93A 1991-12-18 1992-11-18 Transdermal delivery of (E)-1,2,5,6-tetrahydro-1-methyl-3-pyridine-carboxaldehyde-O- methyloxine HCL and related compounds in the treatment of cognitive disorders and for analgesia Abandoned AU3142793A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US809893 1985-12-17
US80989391A 1991-12-18 1991-12-18

Publications (1)

Publication Number Publication Date
AU3142793A true AU3142793A (en) 1993-07-19

Family

ID=25202442

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31427/93A Abandoned AU3142793A (en) 1991-12-18 1992-11-18 Transdermal delivery of (E)-1,2,5,6-tetrahydro-1-methyl-3-pyridine-carboxaldehyde-O- methyloxine HCL and related compounds in the treatment of cognitive disorders and for analgesia

Country Status (5)

Country Link
AU (1) AU3142793A (en)
MX (1) MX9207389A (en)
PT (1) PT101138A (en)
WO (1) WO1993011767A1 (en)
ZA (1) ZA929784B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6525067B1 (en) * 1999-11-23 2003-02-25 Pfizer Inc Substituted heterocyclic derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81610A (en) * 1986-02-27 1990-12-23 Roussel Uclaf Derivatives of 1,2,5,6-tetrahydropyridin-3-carboxaldehyde oxime,their preparation and pharmaceutical compositions containing them
US4786648A (en) * 1986-12-08 1988-11-22 Warner-Lambert Company O-substituted tetrahydropyridine oxime cholinergic agents
US4783450A (en) * 1987-04-13 1988-11-08 Warner-Lambert Company Use of commercial lecithin as skin penetration enhancer
IT1203971B (en) * 1987-04-24 1989-02-23 Roussel Maestretti Spa 1,2,5,6-TETRAHYDROPYRIDINE DERIVATIVES, THEIR PREPARATION PROCEDURE AND THEIR APPLICATION AS MEDICATIONS

Also Published As

Publication number Publication date
MX9207389A (en) 1993-06-01
PT101138A (en) 1994-02-28
WO1993011767A1 (en) 1993-06-24
ZA929784B (en) 1993-06-23

Similar Documents

Publication Publication Date Title
IL112029A (en) Raloxifine and related compounds for use as medicaments for the treatment of disorders associated with an excess of tachykinin
AU4714393A (en) Use of 1,3-dicyclopropymethyl-8-amino-xanthine for the treatment and prevention of type ii diabetes mellitus and obesity
HUP0100069A2 (en) 4(3)substituted-4(3)-aminomethyl-pyran, or -thiopyran-piperidine derivatives, their preparation and their use in the treatment of neurological disorders
HUP0002645A3 (en) Phospholipid containing pharmaceutical composition for treating sleep apnea and apparatus for enabling the administration thereof
IL110204A0 (en) Novel indolene derivatives, processes for their preparation and their use for the treatment of cns disorders
EP0648492A3 (en) Inhibition of phosphatidylinositol 3-kinase with viridin, demethoxyviridin, viridiol, demethoxyviridiol, virone, wortmannolone, and analogs thereof.
AU1197992A (en) The use of loperamide and related compounds for treatment of respiratory disease symptoms
AU2466695A (en) The use of famotidine and related compounds in the treatment of movement disorders
AU6160594A (en) Diabetes prevention and treatment
KR100213963B1 (en) Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis
AU7384094A (en) Use of phenethanolamine derivatives in the treatment of gastrointestinal disorders
EP0683668A4 (en) Compositions and methods for transdermal drug delivery.
AU3717995A (en) Mutant activated gsalpha* and adenylyl cyclase 2 for use as therapeutic agents
DK0583026T3 (en)
CA2135709A1 (en) Melatonin derivatives for use in treating sleep disorders
MY110149A (en) Compounds for the treatment of neurodegenerative disorders
AU3142793A (en) Transdermal delivery of (E)-1,2,5,6-tetrahydro-1-methyl-3-pyridine-carboxaldehyde-O- methyloxine HCL and related compounds in the treatment of cognitive disorders and for analgesia
AU2884489A (en) Compounds with a psychotropic action, agents containing them, and the use thereof for the treatment and prophylaxis of disorders of the central nervous system
AU6678194A (en) Agents for the prevention and treatment of huntington's disease and other neurological disorders
ZA947912B (en) Treatment of medical disorders associated with free radical formation
AU4096789A (en) The use of lactam derivatives in the treatment of cognitive disorders
AU8096094A (en) Use of nicotine substitutes for the treatment of nicotine withdrawal
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
GB2275191B (en) Use of antifungal compounds in the treatment of skin disorders
EP0893123A4 (en) Agent for use in the prevention and treatment of disorders associated with various types of ageing